VENTILATOR ASSOCIATED COMPLICATIONS: OBSERVING IMPLICATIONS OF A NEW SURVEILLANCE PARADIGM by M Yuan et al.
POSTER PRESENTATION Open Access
Ventilator associated complications: observing
implications of a new surveillance paradigm
M Yuan, M Aaland, N Parekh*
From ESICM LIVES 2015
Berlin, Germany. 3-7 October 2015
Introduction
Surveillance for Ventilator Associated Pneumonia (VAP)
is problematic. The CDC published a new surveillance
framework [1] with two main goals.
• Broaden focus of surveillance beyond VAP to
include other common ventilator-associated complica-
tions (VACs).
• Produce objective surveillance definitions using
quantitative data based on changes in ventilator settings.
It introduces a hierarchy of surveillance targets:
1. Ventilator associated complications (VAC). Includes
both pulmonary and non pulmonary complications.
2. Infection related (IVAC) complications with an
infective component.
Objectives
To gain an impression of rates of ventilator acquired
complications using the new CDC criteria and impact
on antibiotic prescription.
Methods
• Inclusion Criteria: All consecutive patients intubated
for at least 48 hours
• Exclusion Criteria: All elective post-cardiac surgery
• Follow Up: Until extubation or death
• Three random period of data collection
• In the first round data on 40 patients were captured
• Four months later in a second round a total of 18
patients were recruited.
Results
First round (Figure 1) on 23 patients shows VAC inci-
dence of 7/23 (30.4%). In VAC group, 4 (17%) met
IVAC criteria as possible pneumonia. Second round
(Figure 2) enrolled 17 patients and shows VAC rate of
1/17 (11%) and that one case was possible pneumonia.
Third round (Figure 3) enrolled 18 patients and shows a
VAC rate of 4/18 (22%). In VAC group, 1 developed
IVAC (6%) as possible pneumonia. Thus VAC rate var-
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ied from 11-30% but IVAC due to pneumonia ranged
from 5-17%.
Conclusions
• New CDC definition for VAC are easy to apply and
removal of subjective criteria must be welcomed
• New definitions of IVAC allows clinicians to
increase antibiotics free rate by 18-37% relatively
• In these 3 cohorts, several patients were treated with
antibiotics despite no evidence to classify as IVAC. This
can only be attributed to subjective decision and inter-
pretation of chest x-ray
• The commonest indication for antibiotic prescription
was non-pulmonary.
• Patients in possible pneumonia group on microbiol-
ogy did not meet other IVAC criteria, highlighting issue
of colonisation being treated with antibiotics
• IVAC metric thus has potential to identify outlier
antibiotic prescribers
• Objective criteria to classify patients into VAC and
IVAC has potential for automation in order to monitor
the incidence of VAC, adding value to clinical dash
board
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